SCHEMBL1479690

SCHEMBL1479690

Cc1cc(F)c(N)cc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
CYP3A4 P08684 4/20 0.39
TSHR P16473 3/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 3/20 0.35
CASP1 P29466 1/20 0.35
CD44 P16070 1/20 0.35
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
TP53 P04637 1/20 0.33
GPR3 P46089 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32
CA6 P23280 1/20 0.32
CA5A P35218 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32
CA14 Q9ULX7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29838774 1.00 ALDH1A1 (0.40) ALDH1A1CYP3A4TSHRMAPK1TDP1
SCHEMBL28913091 0.93 ALDH1A1 (0.36) ALDH1A1CYP3A4TSHRMAPK1TDP1
SCHEMBL16660691 0.89 CYP3A4 (0.46) ALDH1A1CYP3A4TSHRMAPK1TDP1
SCHEMBL405476 0.86 CD44 (0.48) ALDH1A1CYP3A4TSHRMAPK1TDP1
SCHEMBL29791306 0.86 CYP3A4 (0.55) ALDH1A1CYP3A4TSHRMAPK1TDP1
SCHEMBL3873719 0.86 CYP3A4 (0.55) ALDH1A1CYP3A4TSHRMAPK1TDP1
SCHEMBL832391 0.83 CYP3A4 (0.60) ALDH1A1CYP3A4TSHRMAPK1TDP1
SCHEMBL29358157 0.83 CYP3A4 (0.52) ALDH1A1CYP3A4TSHRMAPK1TDP1
SCHEMBL457125 0.83 CYP3A4 (0.52) ALDH1A1CYP3A4TSHRMAPK1TDP1
SCHEMBL28606707 0.83 CYP3A4 (0.60) ALDH1A1CYP3A4TSHRMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112851493-B Preparation method of 2,4, 5-trifluoro phenylacetic acid 台州臻挚生物科技有限公司 2022-09-06 CN claimed
WO-2022099439-A1 PREPARATION METHOD FOR 2,4,5-TRIFLUOROPHENYLACETIC ACID 杭州臻挚生物科技有限公司 2022-05-19 WO claimed
CN-112851493-A Preparation method of 2,4, 5-trifluorophenylacetic acid 杭州臻挚生物科技有限公司 2021-05-28 CN claimed
US-12391663-B2 Isoindolinone compounds MONTE ROSA THERAPEUTICS AG (CH) 2025-08-19 US disclosed
US-20240261274-A1 TREATMENT OF MYC-DRIVEN CANCERS WITH GSPT1 DEGRADERS MONTE ROSA THERAPEUTICS AG (CH) 2024-08-08 US disclosed
US-20240083869-A1 ISOINDOLINONE COMPOUNDS MONTE ROSA THERAPEUTICS AG (CH) 2024-03-14 US disclosed
US-11912682-B2 Isoindolinone compounds MONTE ROSA THERAPEUTICS, INC. (US) 2024-02-27 US disclosed
CN-117242060-A Isoindolinone compounds 蒙特罗萨医疗公司 2023-12-15 CN disclosed
EP-4277901-A1 ISOINDOLINONE COMPOUNDS Monte Rosa Therapeutics, Inc. (US) 2023-11-22 EP disclosed
EP-4278014-A1 TREATMENT OF MYC-DRIVEN CANCERS WITH GSPT1 DEGRADERS Monte Rosa Therapeutics, Inc. (US) 2023-11-22 EP disclosed
US-20230348418-A1 ISOINDOLINONE COMPOUNDS MONTE ROSA THERAPEUTICS AG (CH) 2023-11-02 US disclosed
US-8357633-B2 2-(2-fluoro-substituted phenyl)-6-amino-5-chloro-4-pyrimidinecarboxylates and their use as herbicides DOW AGROSCIENCES, LLC (US) 2013-01-22 US disclosed
EP-2176239-B1 2-(2-FLUORO-SUBSTITUTED PHENYL)-6-AMINO-5-CHLORO-4-PYRIMIDINECARBOXYLATES AND THEIR USE AS HERBICIDES DOW AGROSCIENCES LLC (US) 2012-12-19 EP disclosed
EP-2311815-B1 2-(2-Fluoro-substituted phenyl)-6-amino-5-chloro-4-pyrimidinecarboxylates and their use as herbicides DOW AGROSCIENCES LLC (US) 2012-12-19 EP disclosed
EP-2311815-A1 2-(2-Fluoro-substituted phenyl)-6-amino-5-chloro-4-pyrimidine carboxylates and their use as herbicides Dow AgroSciences LLC (US) 2011-04-20 EP disclosed
US-7915200-B2 2-(2-fluoro-substituted phenyl)-6-amino-5-chloro-4-pyrimidinecarboxylates and their use as herbicides DOW AGROSCIENCES LLC (US) 2011-03-29 US disclosed
US-20100120621-A1 2-(2-FLUORO-SUBSTITUTED PHENYL)-6-AMINO-5-CHLORO-4-PYRIMIDINECARBOXYLATES AND THEIR USE AS HERBICIDES DOW AGROSCIENCES LLC (US) 2010-05-13 US disclosed
EP-2176239-A1 2-(2-FLUORO-SUBSTITUTED PHENYL)-6-AMINO-5-CHLORO-4-PYRIMIDINECARBOXYLATES AND THEIR USE AS HERBICIDES Dow AgroSciences LLC (US) 2010-04-21 EP disclosed
WO-2009023438-A1 2-(2-FLUORO-SUBSTITUTED PHENYL)-6-AMINO-5-CHLORO-4-PYRIMIDINECARBOXYLATES AND THEIR USE AS HERBICIDES DOW AGROSCIENCES LLC (US) 2009-02-19 WO disclosed
US-20090048109-A1 2-(2-FLUORO-SUBSTITUTED PHENYL)-6-AMINO-5-CHLORO-4-PYRIMIDINECARBOXYLATES AND THEIR USE AS HERBICIDES DOW AGROSCIENCES LLC (US) 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120621-A1 2-(2-FLUORO-SUBSTITUTED PHENYL)-6-AMINO-5-CHLORO-4-PYRIMIDINECARBOXYLATES AND THEIR USE AS HERBICIDES DDT, DDC, PFAS ALDH1A1 314/4885CYP3A4 500/4885TSHR 2129/4885
US-20090048109-A1 2-(2-FLUORO-SUBSTITUTED PHENYL)-6-AMINO-5-CHLORO-4-PYRIMIDINECARBOXYLATES AND THEIR USE AS HERBICIDES DDT, DDC, PFAS ALDH1A1 348/4885CYP3A4 471/4885TSHR 2046/4885
US-12391663-B2 Isoindolinone compounds CYP4F2, AOC2, AOC3 ALDH1A1 1142/4885CYP3A4 684/4885TSHR 1114/4885
US-20240083869-A1 ISOINDOLINONE COMPOUNDS CYP4F2, AOC2, AOC3 ALDH1A1 1142/4885CYP3A4 684/4885TSHR 1114/4885
US-20230348418-A1 ISOINDOLINONE COMPOUNDS CYP4F2, AOC2, AOC3 ALDH1A1 1370/4885CYP3A4 715/4885TSHR 1131/4885
US-11912682-B2 Isoindolinone compounds CYP4F2, AOC2, AOC3 ALDH1A1 1142/4885CYP3A4 684/4885TSHR 1114/4885
US-20240261274-A1 TREATMENT OF MYC-DRIVEN CANCERS WITH GSPT1 DEGRADERS MYC, MYCBP, GSPT1 ALDH1A1 4276/4885CYP3A4 4304/4885TSHR 2333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.